Construction of oncolytic reporter influenza viral vectors and assessment of their safety following intracranial administration in rats

Construction of oncolytic reporter influenza viral vectors and assessment of their safety following intracranial administration in rats

INTRODUCTION: Oncolytic viruses are a promising approach for treating malignant brain tumors as part a of combination therapy. OBJECTIVE: To develop reporter influenza A viruses expressing NanoLuc luciferase and evaluate their safety following intracranial administration in rats. METHODS: Chemilu...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. A. Pulkina, A. S. Mustafaeva, E. A. Romanovskaya-Romanko, M. A. Plotnikova, O. O. Ozhereleva, M. A. Shuklina, L. N. Kiseleva, Y. S. Alekseeva, N. S. Kurmazov, A. R. Muslimov, A.-P.S. Shurygina, M. A. Stukova
Format:	Article
Language:	English
Published:	Doctrine 2024-11-01
Series:	Microbiology Independent Research Journal
Online Access:	https://www.scienceopen.com/hosted-document?doi=10.18527/202411105118
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

In Vitro Evaluation of the Antiviral Properties of Exogenous mRNA Encoding the Human MxA Protein
by: Marina A. Plotnikova, et al.
Published: (2025-01-01)

Neuraminidase Antibody Response to Homologous and Drifted Influenza A Viruses After Immunization with Seasonal Influenza Vaccines
by: Yulia Desheva, et al.
Published: (2024-11-01)

Modern Approaches to Enterovirus-Based Oncolytic Immune Virotherapy of Malignant Diseases
by: E. R. Nemtsova, et al.
Published: (2025-07-01)

EFFECTIVENESS OF CROSS-PROTECTIVE RECOMBINANT INFLUENZA VACCINE BASED ON CONSERVED EPITOPES OF VIRAL PROTEINS М2 AND HEMAGGLUTININ
by: L. A. Stepanova, et al.
Published: (2018-01-01)

Clinical trials on oncolytic viruses
by: I. V. Golovinov, et al.
Published: (2025-01-01)

Development and evaluation of a recombinant monoclonal human antibody with virus-neutralizing activity against the F glycoprotein of respiratory syncytial virus
by: Sergey A. Klotchenko, et al.
Published: (2024-12-01)

Oncolytic Viruses
by: Nanhai G. Chen, et al.
Published: (2012-01-01)

Viral Oncolytic Therapy
by: Omar Zurkiya, et al.
Published: (2017-07-01)

INDUCTION OF LONG-TERM T AND B CELL MEMORY IMMUNITY TO INFLUENZA A VIRUS (H5N1) IN PERSONS VACCINATED WITH LIVE INFLUENZA A VACCINE (H5N2)
by: I. V. Losev, et al.
Published: (2017-08-01)

Intranasal immunization with a recombinant protein based on the M2e peptide and second subunit of influenza A viral hemagglutinin fragment induces a cross-protective humoral and Tcell response in mice
by: M. A Shuklina, et al.
Published: (2020-04-01)

Oncolytic bacteria: A revolutionary approach to cancer therapy
by: Khormi Mohsen A., et al.
Published: (2025-06-01)

Strengthening the Effectiveness of the Candidate Influenza Vaccine by Combining Conserved Sequences of Hemagglutinin and M2 protein
by: L. M. Tsybalova, et al.
Published: (2017-06-01)

ONCOLYTIC VIROTHERAPY IN GLIOBLASTOMA TREATMENT: PROGRESS AND CHALLENGES IN CLINICAL RESEARCH (LITERATURE REVIEW)
by: O. I. Kit, et al.
Published: (2020-12-01)

Comparative analysis of oncolytic potential of vesicular stomatitis virus serotypes Indiana and New Jersey in cancer cell lines
by: A. S. Isaeva, et al.
Published: (2023-12-01)

Study of the possibilities of non-invasive assessment of increased intracranial pressure according to MRI data on the example of patients with secondary intracranial hypertension
by: N. N. Sidikov, et al.
Published: (2024-03-01)

Inflammatory Response in Patients with Spontaneous Intracranial Hemorrhages
by: L. M. Tsentsiper, et al.
Published: (2022-10-01)

Evaluation of the preventive effectiveness of influenza vaccines in St. Petersburg
by: M. K. Erofeeva, et al.
Published: (2020-11-01)

Assessment of influenza and COVID-19 vaccine epidemiologic efficacy in the 2020–2021, 2021–2022, 2022–2023 seasons in Novosibirsk
by: Teresa A. Saroyan, et al.
Published: (2025-04-01)

Chimeric Virus-like Particles of Physalis Mottle Virus as Carriers of M2e Peptides of Influenza a Virus
by: Elena A. Blokhina, et al.
Published: (2024-11-01)

Advanced Therapy Medicines Based on Oncolytic Viruses (Part I: Development and Authorisation of Products in China)
by: E. V. Melnikova, et al.
Published: (2021-10-01)

The 16th International Oncolytic Virus Conference: Advancing oncolytic virotherapy by balancing anti-tumor and anti-viral immunity
by: Eftychia Stavrakaki, et al.
Published: (2025-03-01)

Investigation of Susceptibility of Influenza Viruses A (H1N1), the Cause of Infection in Humans in April - May 2009, to Antivirals in MDCK Cell Culture
by: A. A. Romanovskaya, et al.
Published: (2020-05-01)

The impact of vaccination against influenza and pneumococcal infection on the incidence of acute respiratory viral infections and community-acquired pneumonia in the Central Administrative District of Moscow
by: O. A. Gruzdeva, et al.
Published: (2021-05-01)

Influence of oncolytic strains of a new unclassified group of human rotaviruses on peripheral blood lymphocytes
by: O. I. Kit, et al.
Published: (2021-09-01)

Zika virus has an oncolytic activity against human glioblastoma U87 cells
by: V. A. Svyatchenko, et al.
Published: (2019-01-01)

Evaluation of the Preventive Effectiveness of Influenza Vaccines in the Epidemic Season 2019–2020 in St. Petersburg
by: M. K. Erofeeva, et al.
Published: (2021-11-01)

Otogenic intracranial pyo-inflammatory complications
by: A. A. Krivopalov, et al.
Published: (2017-12-01)

Echographic criteria for the assessment of the optic nerve condition in intracranial hypertension
by: V. V. Neroev, et al.
Published: (2022-12-01)

Clinical and epidemiologic efficacy of late interferon inductor in in the prevention of acute respiratory viral infections and influenza in 2017–2018 pre-epidemic period
by: V. A. Petrov, et al.
Published: (2021-06-01)

Initial dose of oncolytic myxoma virus programs durable antitumor immunity independent of in vivo viral replication
by: Eric Bartee, et al.
Published: (2020-05-01)

The dual promise of oncolytic viruses: selective targeting and therapeutic enhancement in cancer treatment
by: Alaa A. A. Aljabali, et al.
Published: (2025-07-01)

VARIABILITY OF THE INFLUENZA A VIRUS
by: I. A. Sobolev, et al.
Published: (2016-03-01)

Insights from veterinary models for advancing oncolytic virotherapy through comparative oncology
by: Almohanad A. Alkayyal
Published: (2025-05-01)

On solvability of a nonlocal problem with integral conditions for hyperbolic equation in characteristic domain
by: L. S. Pulkina, et al.
Published: (2025-06-01)

Complex study of morphoconstitutional indicators of patients with diabetes mellitus according to variative distribution of subcutaneous fat
by: A. G. Mustafaeva
Published: (2011-03-01)

The study of oncolytic viruses reproduction in organ cultures of human lymphoid tumors
by: F. E. Babaeva, et al.
Published: (2019-12-01)

Retargeting of Viruses to Generate Oncolytic Agents
by: M. H. Verheije, et al.
Published: (2012-01-01)

The Potency of Mesenchymal Stem Cells as Viral Oncolytic Carriers
by: Muhammad Farid Rakhman
Published: (2024-11-01)

Antiviral Activity of Ingavirin® in Experimental Lethal Influenza Due to Influenza Virus B in Albino Mice
by: V. V. Zarubaev, et al.
Published: (2020-05-01)

Influenza B virus evolution: diversity of biological properties through the prism of genetic variability
by: Irina V. Kiseleva, et al.
Published: (2024-12-01)